Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS

SUNY Upstate Medical University, Syracuse

Lehigh Valley Health Network, Allentown

Johns Hopkins University, Baltimore

University of Virginia Health System, Charlottesville

Duke University, Durham

Augusta University, Augusta

Mayo Clinic, Jacksonville

Indiana University IU Health Neuroscience Center, Indianapolis

Hennepin Healthcare Research Institute, Minneapolis

University of California, Orange

University of Alberta Hospital, Edmonton

McMaster University Medical Center, Hamilton

Sunnybrook Research Institute, Toronto

Montreal Neurological Institute and Hospital, Montreal

University of Saskatchewan - Sastakoon Hospital, Saskatoon

Hopital de L'Enfant-Jesus, CHU de Quebec-Universite Laval, Québec